December 10, 2025 – Tulane Ventures has invested $125,000 in Beken Bio, a biotechnology company developing early-detection blood tests for some of the deadliest forms of cancer that are often diagnosed too late.
The company is led by founder and CEO, Christopher Millan, PhD, a New Orleans native and 2009 Tulane University School of Science and Engineering graduate who recently expanded his company to the Crescent City from San Diego.